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Introduction
Familial Mediterranean Fever (FMF) is the most com-
mon periodic fever syndrome, characterized by recurrent
fever, serositis attacks. There are limited data on comor-
bidities seen in patients with FMF.
Objective
Our objective was to evaluate comorbidities among indi-
viduals with FMF in a large cohort.
Methods
We used Hacettepe University- Department of Medical
Biology’s genetic database records of 5636 FMF patients
for MEFV mutation. 1998 patients among this group
who are followed by rheumatologists in our hospital,
with homozygous and compound heterozygous MEFV
mutations were included in the study. We analyzed,
Hacettepe University clinical records.
Results
The mean age was 27,5±16 (1-86) years. Our hospital
mean follow-up period was 48,5±48 (1-352) months.
1343 patients (67,2%) had no comorbidities. 655 patients
(32.8%) had comorbidities. Comorbidities were as follow:
Appendectomy 30 (4,6%), cholecystectomy 20 (3,1%),
acute rheumatic fever (2,4%), ankylosing spondylitis 155
(23,7%), juvenile idiopathic arthritis 31 (4,6%), rheuma-
toid arthritis 10 (1,5%), renal amyloidosis 54 (8,2%),
intestinal amyloidosis 4 (0,6%), chronic renal failure 33
(5%), Behçet’s disease 1 (0,2%), Henoch-Schönlein pur-
pura 25 (3,8%), osteoporosis 77 (11,8%), celiac disease
5 (0,8%), inflammatory bowel disease 16 (2,4%), hepatos-
plenomegaly 33 (5%), hepatosteatosis 20 (3,1%),
hypertension 53 (8,1%), polyarteritis nodosa 9 (1,4%),
epilepsy 7 (1,1%), multiple sclerosis 5 (0,8%), PFAPA
4 (0,6%), uveitis 1 (0,2%), asthma 6 (0,9%), IgA defi-
ciency 4 (0,6%), thalassemia trait 8 (1,2 %), thalassemi
major 1 (0,2 %), systemic lupus erythematosus 5 (0,8 %),
sjogren syndrome 2 (0,4%), autoimmune hepatitis
2 (0,4%), autoimmune hemolytic anemia 2 (0,4%) …
Homozygous M694V frequency in patients with comor-
bidities was 42,7% while it was 34,4% in those without
comorbidities. M694V/M694V mutation in patients with
comorbidities was significantly more frequent.
Conclusion
These comorbidities can be classified in 3 groups: those
comorbidities directly related to FMF such as amyloidosis,
the second being comorbidities that may be incidental
such as IgA deficiency. The last group of comorbidities
were those associated with FMF due to increased innate
inflammation such as PAN, PFAPA.
It is important to establish the relationship between
different diseases’ phenotypes and pathologies underly-
ing cellular functions. Thus the results of our study
would lead to improved clinical care and epidemiology
in FMF.
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